Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity.

Journal of Leukocyte Biology
Shawna F GravesFrank R Deleo

Abstract

CA-MRSA infections are often caused by strains encoding PVL, which can cause lysis of PMNs and other myeloid cells in vitro, a function considered widely as the primary means by which PVL might contribute to disease. However, at sublytic concentrations, PVL can function as a PMN agonist. To better understand this phenomenon, we investigated the ability of PVL to alter human PMN function. PMNs exposed to PVL had enhanced capacity to produce O(2)(-) in response to fMLF, but unlike priming by LPS, this response did not require TLR signal transduction. On the other hand, there was subcellular redistribution of NADPH oxidase components in PMNs following exposure of these cells to PVL--a finding consistent with priming. Importantly, PMNs primed with PVL had an enhanced ability to bind/ingest and kill Staphylococcus aureus. Priming of PMNs with other agonists, such as IL-8 or GM-CSF, altered the ability of PVL to cause formation of pores in the plasma membranes of these cells. Microarray analysis revealed significant changes in the human PMN transcriptome following exposure to PVL, including up-regulation of molecules that regulate the inflammatory response. Consistent with the microarray data, mediators of the inflammatory response w...Continue Reading

References

Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S HaskillR Sager
Nov 1, 1984·The Journal of Clinical Investigation·M BergerM M Frank
Feb 7, 1998·The Journal of Clinical Investigation·F R DeLeoW M Nauseef
Mar 5, 1998·JAMA : the Journal of the American Medical Association·B C HeroldR S Daum
Jan 3, 2001·The Journal of Clinical Investigation·P P Tak, G S Firestein
Mar 20, 2001·Infection and Immunity·V GauduchonD A Colin
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ian SabroeSteven K Dower
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Scott D KobayashiFrank R DeLeo
Jun 5, 2002·Lancet·Tadashi BabaKeiichi Hiramatsu
Jan 14, 2003·Annual Review of Immunology·Renato C Monteiro, Jan G J Van De Winkel
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ian SabroeMoira K B Whyte
Jun 24, 2003·Infection and Immunity·Didier A Colin, Henri Monteil
Nov 10, 1962·British Medical Journal·C H LACK, A G TOWERS
Sep 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jovanka M VoyichFrank R DeLeo
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Dec 3, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C BadiouG Lina
Jan 22, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M CrozeG Lina
Mar 19, 2009·Proceedings of the National Academy of Sciences of the United States of America·Min LiMichael Otto
Sep 5, 2009·The Journal of Clinical Investigation·Frank R DeLeo, Henry F Chambers
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Pauline Yoong, Gerald B Pier
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Binh An DiepHenry F Chambers
Oct 16, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christina R HermosGerald B Pier
Dec 24, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana ZivkovicSylvia Knapp

❮ Previous
Next ❯

Citations

Jun 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·Ashley L DuMontVictor J Torres
Aug 9, 2012·The Journal of Infectious Diseases·Natalia MalachowaFrank R Deleo
Mar 8, 2013·Current Opinion in Microbiology·Pauline Yoong, Victor J Torres
Apr 23, 2016·The International Journal of Biochemistry & Cell Biology·Chunyang DaiXiaoling Ma
May 21, 2013·Cell Host & Microbe·András N SpaanJos A G van Strijp
Jan 21, 2015·The International Journal of Biochemistry & Cell Biology·Wulin ShanXiaoling Ma
Apr 20, 2017·Nature Reviews. Microbiology·András N SpaanVictor J Torres
May 23, 2014·Microbiology and Molecular Biology Reviews : MMBR·Francis Alonzo, Victor J Torres
Nov 14, 2014·Current Opinion in Hematology·Mallary Greenlee-WackerWilliam M Nauseef
Nov 6, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Natalia MalachowaFrank R DeLeo
Jul 18, 2017·Frontiers in Cellular and Infection Microbiology·Fermin E GuerraJovanka M Voyich
Dec 15, 2016·FEMS Microbiology Reviews·Helene BuvelotKarl-Heinz Krause
Nov 27, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Viola MazzoleniGilles Prévost
Feb 2, 2021·Virulence·Gordon Y C CheungMichael Otto
Mar 16, 2019·Microbiology Spectrum·Kayan Tam, Victor J Torres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Pauline Yoong, Gerald B Pier
Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Shawna F GravesFrank R Deleo
Proceedings of the National Academy of Sciences of the United States of America
Binh An DiepHenry F Chambers
© 2021 Meta ULC. All rights reserved